Overall and relapse-free survival rates in AML cases with and without... | Download Scientific Diagram
![Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni, Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni,](https://journals.sagepub.com/cms/10.1177/13524585211010294/asset/images/large/10.1177_13524585211010294-fig2.jpeg)
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni,
Prognosis of patients with core binding factor acute myeloid leukemia after first relapse | Haematologica
![A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data - ScienceDirect A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2210909914001234-gr3.jpg)
A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data - ScienceDirect
![Overall and relapse-free survival rates in AML cases with and without... | Download Scientific Diagram Overall and relapse-free survival rates in AML cases with and without... | Download Scientific Diagram](https://www.researchgate.net/profile/Hayato-Tamai/publication/303716743/figure/fig3/AS:667697163558933@1536202817819/Overall-and-relapse-free-survival-rates-in-AML-cases-with-and-without-DMRGM-A-Overall_Q640.jpg)
Overall and relapse-free survival rates in AML cases with and without... | Download Scientific Diagram
![At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial - Ganzel - 2020 - British Journal of Haematology - Wiley Online Library At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial - Ganzel - 2020 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d4a1c1ab-514e-41b0-9469-7050003752cd/bjh16616-fig-0001-m.jpg)
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial - Ganzel - 2020 - British Journal of Haematology - Wiley Online Library
![Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study | International Journal of Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study | International Journal of](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13033-021-00464-0/MediaObjects/13033_2021_464_Fig2_HTML.png)
Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study | International Journal of
![Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program | Annals of General Psychiatry | Full Text Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program | Annals of General Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12991-020-00269-4/MediaObjects/12991_2020_269_Fig2_HTML.png)
Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program | Annals of General Psychiatry | Full Text
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group | Haematologica
![Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/1b1e5ec1-3d15-4344-9277-dd1d26e06c7e/mfig002.jpg)
Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library
![A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data - ScienceDirect A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2210909914001234-gr1.jpg)
A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data - ScienceDirect
![Predictors of relapse and overall survival in Philadelphia chromosome–positive acute lymphoblastic leukemia after transplantation - Biology of Blood and Marrow Transplantation Predictors of relapse and overall survival in Philadelphia chromosome–positive acute lymphoblastic leukemia after transplantation - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d404db44-504b-4f3f-9518-c59d6f9843c5/gr1.jpg)
Predictors of relapse and overall survival in Philadelphia chromosome–positive acute lymphoblastic leukemia after transplantation - Biology of Blood and Marrow Transplantation
![Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni, Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni,](https://journals.sagepub.com/cms/10.1177/13524585211010294/asset/images/large/10.1177_13524585211010294-fig3.jpeg)